Related Experiment Video
Updated: Jul 2, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Fenbendazole-Associated Drug-Induced Liver Injury with Concomitant Use of Tauroursodeoxycholic Acid
Alexander Satinsky1, Nancy Mayer1, Charles Swanson1
1Riverside Medical Center, Kankakee, IL.
None:
Influenced by the internet and social media, a growing number of individuals are taking hepatotoxic amounts of prescription and nonprescription drugs leading to drug-induced liver injuries (DILIs). We present a case of fenbendazole-associated DILI with concomitant use of tauroursodeoxycholic acid as an intended hepatoprotective agent. While fenbendazole-associated DILI has been increasingly reported, this case is unique due to associated tauroursodeoxycholic acid use, and, to our knowledge, represents the first published report of this exposure combination. This case builds on the growing literature of DILI due to nonprescription drugs and highlights the importance of patient-centered counseling.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Risk factors
Drug Toxicity: Overview
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Toxicity: Dose-Dependent Reactions